Page last updated: 2024-08-23

flubendazole and Cancer of Intestines

flubendazole has been researched along with Cancer of Intestines in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Čáňová, K; Hanušová, V; Knoppová, K; Králová, V; Skálová, L; Staňková, P	1

Other Studies

1 other study(ies) available for flubendazole and Cancer of Intestines

Article	Year
Antiproliferative effect of benzimidazole anthelmintics albendazole, ricobendazole, and flubendazole in intestinal cancer cell lines. Anti-cancer drugs, 2013, Volume: 24, Issue:9 Topics: Adenocarcinoma; Albendazole; Anthelmintics; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Cell Line, Tumor; Cell Proliferation; Cell Survival; Drug Resistance, Neoplasm; Drug Synergism; G2 Phase; Humans; Inhibitory Concentration 50; Intestinal Neoplasms; Mebendazole; Microtubules; Paclitaxel; Protein Stability; Tubulin Modulators	2013

Article

Year

Antiproliferative effect of benzimidazole anthelmintics albendazole, ricobendazole, and flubendazole in intestinal cancer cell lines.

Anti-cancer drugs, 2013, Volume: 24, Issue:9

Topics: Adenocarcinoma; Albendazole; Anthelmintics; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Cell Line, Tumor; Cell Proliferation; Cell Survival; Drug Resistance, Neoplasm; Drug Synergism; G2 Phase; Humans; Inhibitory Concentration 50; Intestinal Neoplasms; Mebendazole; Microtubules; Paclitaxel; Protein Stability; Tubulin Modulators

2013